| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Uwe Trieschmann | Q74119044 |
| P2093 | author name string | M Khalil | |
| M Emmel | |||
| N Sreeram | |||
| P2860 | cites work | Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients | Q74431196 |
| Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia | Q78390804 | ||
| Contribution of long-QT syndrome genes to sudden infant death syndrome: is it time to consider newborn electrocardiographic screening? | Q79622487 | ||
| Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands | Q80794295 | ||
| Assessment of markers for identifying patients at risk for life-threatening arrhythmic events in Brugada syndrome | Q81324909 | ||
| Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest | Q81414753 | ||
| Effect of clinical phenotype on yield of long QT syndrome genetic testing | Q82601578 | ||
| Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study | Q84292779 | ||
| Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations | Q24529526 | ||
| Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org) | Q24654954 | ||
| Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death | Q24675134 | ||
| Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia | Q28201561 | ||
| The genetic basis of Brugada syndrome: a mutation update | Q28252115 | ||
| The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading [...] | Q28265202 | ||
| Genetic basis and molecular mechanism for idiopathic ventricular fibrillation | Q28265902 | ||
| Prevalence of long-QT syndrome gene variants in sudden infant death syndrome | Q28282448 | ||
| Catecholaminergic polymorphic ventricular tachycardia | Q28287523 | ||
| Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data | Q31111759 | ||
| Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. | Q33145050 | ||
| Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. | Q33146000 | ||
| Prognostic value of electrophysiologic investigations in Brugada syndrome | Q33146886 | ||
| Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel | Q33147394 | ||
| Natural history of Brugada syndrome: insights for risk stratification and management | Q33147491 | ||
| Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. | Q33147854 | ||
| Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia | Q33148058 | ||
| Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart | Q33148999 | ||
| Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest | Q33150723 | ||
| Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations | Q33151146 | ||
| Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan | Q33151556 | ||
| Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome | Q33151705 | ||
| Efficacy of quinidine in high-risk patients with Brugada syndrome | Q33151791 | ||
| Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases | Q33152066 | ||
| Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome | Q33152228 | ||
| Catecholaminergic polymorphic ventricular tachycardia. | Q33152560 | ||
| Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome | Q33153396 | ||
| The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome | Q33153549 | ||
| Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. | Q33153802 | ||
| Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis | Q33154041 | ||
| Electrocardiographic risk stratification in families with congenital long QT syndrome | Q33154118 | ||
| Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome | Q33154257 | ||
| Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study | Q33154495 | ||
| Clinical aspects and prognosis of Brugada syndrome in children | Q33154976 | ||
| Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene | Q33155088 | ||
| Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia | Q33155477 | ||
| Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan | Q33155552 | ||
| Long-QT syndrome after age 40. | Q33156197 | ||
| Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome | Q33156201 | ||
| Risk of death in the long QT syndrome when a sibling has died | Q33156334 | ||
| QT interval prolongation and risk for cardiac events in genotyped LQTS-index children | Q33156950 | ||
| Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia | Q33157356 | ||
| Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy | Q33157716 | ||
| Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients | Q33173888 | ||
| Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. | Q33175786 | ||
| Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). | Q33175954 | ||
| Of founder populations, long QT syndrome, and destiny | Q33575898 | ||
| Genotype-phenotype aspects of type 2 long QT syndrome | Q33598557 | ||
| Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome | Q33772836 | ||
| Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent | Q33877950 | ||
| Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome | Q34232976 | ||
| A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y | Q34331339 | ||
| Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. | Q34385271 | ||
| Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry | Q34422572 | ||
| Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. | Q34514756 | ||
| Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7). | Q34658342 | ||
| State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young | Q35904771 | ||
| Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes | Q35909999 | ||
| The congenital long QT syndromes from genotype to phenotype: clinical implications | Q36335249 | ||
| Genotype-specific ECG patterns in long QT syndrome | Q36590127 | ||
| Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome | Q36724804 | ||
| Importance of Knowing the Genotype and the Specific Mutation When Managing Patients with Long QT Syndrome | Q37313296 | ||
| Clinical impact of genetic studies in lethal inherited cardiac arrhythmias | Q37316335 | ||
| Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias | Q37339393 | ||
| Fragmented QRS: a predictor of mortality and sudden cardiac death. | Q37404121 | ||
| Genotyping has a minor role in selecting therapy for congenital long-QT syndromes at present | Q37609712 | ||
| Fragmented QRS and other depolarization abnormalities as a predictor of mortality and sudden cardiac death | Q37625740 | ||
| Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations. | Q40508700 | ||
| Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: A computational analysis | Q40865508 | ||
| Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits | Q41020380 | ||
| KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome | Q42665516 | ||
| Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies | Q43590112 | ||
| Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome | Q44031334 | ||
| Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks | Q44101230 | ||
| Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges. | Q45933724 | ||
| Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome. | Q46038927 | ||
| Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population | Q46301151 | ||
| Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response | Q46988579 | ||
| Compound mutations: a common cause of severe long-QT syndrome | Q47857406 | ||
| Postmortem long QT syndrome genetic testing for sudden unexplained death in the young | Q48480320 | ||
| Cardiac sodium channel gene variants and sudden cardiac death in women | Q48770773 | ||
| Long QT syndrome in children: not one disease anymore. | Q50901158 | ||
| Long QT syndrome in children in the era of implantable defibrillators. | Q50901163 | ||
| Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. | Q51145417 | ||
| Risk stratification in patients with Brugada syndrome: analysis of daily fluctuations in 12-lead electrocardiogram (ECG) and signal-averaged electrocardiogram (SAECG). | Q51165138 | ||
| Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. | Q51636642 | ||
| Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. | Q51969927 | ||
| The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. | Q53809565 | ||
| Genetic Modulation of Brugada Syndrome by a Common Polymorphism | Q57239689 | ||
| Neural Control of Heart Rate Is an Arrhythmia Risk Modifier in Long QT Syndrome | Q57744807 | ||
| High Efficacy of β-Blockers in Long-QT Syndrome Type 1 | Q58010685 | ||
| Cost-effectiveness of neonatal ECG screening for the long QT syndrome | Q58010811 | ||
| Electrocardiographic Prediction of Abnormal Genotype in Congenital Long QT Syndrome: Experience in 101 Related Family Members | Q58010947 | ||
| How really rare are rare diseases?: the intriguing case of independent compound mutations in the long QT syndrome | Q64048552 | ||
| ECG T-Wave Patterns in Genetically Distinct Forms of the Hereditary Long QT Syndrome | Q71807499 | ||
| Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes | Q73265460 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 257-273 | |
| P577 | publication date | 2010-06-05 | |
| P1433 | published in | Indian Pacing and Electrophysiology Journal | Q15734361 |
| P1476 | title | Risk stratification in young patients with channelopathies | |
| P478 | volume | 10 |
Search more.